Carisma Therapeutics CSO Klichinsky Michael sells 56982 shares, buys 56982 at lower price.

Carisma Therapeutics Inc. (CARM) has announced that Chief Scientific Officer Michael Klichinsky has engaged in a transaction involving 56,982 shares of the company's stock. Specifically, on October 7, 2025, Mr. Klichinsky sold 56,982 shares at a price of $0.25 per share. Later the same day, he purchased 56,982 shares at a price of $0.11 per share.